Clinical Trials on Platelet Coagulation Disorders in China

Total 9030 results

The First Affiliated Hospital of Soochow University

Recruiting

Avatrombopag to Promote Platelet Engraftment After Allo-HSCT

Platelet Disorder

China
Nanfang Hospital, Southern Medical University

Recruiting

The Role of Circ0014614 in the Formation and Development of ET

Primary Thrombocytosis

China
Institute of Hematology & Blood Diseases Hospital...

Recruiting

Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Adult Essential Thrombocythemia

Essential Thrombocytopenia

China
Institute of Hematology & Blood Diseases Hospital...

Recruiting

Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Childhood and Adolescent Essential Thrombocythemia

Essential Thrombocytopenia

China
Peking University People's Hospital
Beijing Friendship Hospital; Beijing Tongren Hospital; Beijing Hospital; Navy General...

Not yet recruiting

The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9

Purpura, Thrombocytopenic, Idiopathic

China
Ruijin Hospital

Recruiting

The Impact of Coagulation Disorders on the Diagnosis and Prognosis of Sepsis

Sepsis | Coagulation Disorder

China
Peking University People's Hospital

Recruiting

Teriflunomide for Steroid-resistant/Relapse Immune Thrombocytopenia

Immune Thrombocytopenia

China
Peking University People's Hospital

Recruiting

The Combination of Tacrolimus and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Immune Thrombocytopenia

China
Peking University People's Hospital
Beijing Tongren Hospital; Beijing Hospital; Navy General Hospital, Beijing

Unknown

The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Immune Thrombocytopenia

China
Peking University People's Hospital
Qilu Hospital of Shandong University; Beijing Hospital; Navy General Hospital...

Unknown

A Study of ATRA in the Treatment of ITP

Immune Thrombocytopenia

China
Peking University People's Hospital

Unknown

The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Immune Thrombocytopenia

China
Peking University People's Hospital

Unknown

The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP

Immune Thrombocytopenia

China
Shandong University
Peking Union Medical College Hospital; Cancer Institute and Hospital, Chinese... and other collaborators

Completed

High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)

Purpura, Thrombocytopenic, Idiopathic

China
Peking University People's Hospital
Peking University First Hospital; Beijing Friendship Hospital; Chinese PLA General... and other collaborators

Recruiting

The Combination of Teriflunomide and Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia

Immune Thrombocytopenia

China
Peking University People's Hospital
Peking University First Hospital; Beijing Friendship Hospital; Chinese PLA General... and other collaborators

Recruiting

Low-dose Baricitinib Plus High-dose Dexamethasone for Patients With Newly Diagnosed Immune Thrombocytopenia

Immune Thrombocytopenia

China
Peking University People's Hospital
Peking University First Hospital; Beijing Friendship Hospital; Chinese PLA General... and other collaborators

Recruiting

Low-dose Baricitinib Plus Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia

Immune Thrombocytopenia

China
Peking University People's Hospital

Not yet recruiting

Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune Thrombocytopenia

Immune Thrombocytopenia

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Hetrombopag for Pediatric Patients With Chronic Immune Thrombocytopenia

Immune Thrombocytopenia

China
Peking University People's Hospital
Peking University First Hospital; Beijing Friendship Hospital; Chinese PLA General... and other collaborators

Recruiting

Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia

Immune Thrombocytopenia

China
Peking University People's Hospital
Qilu Hospital of Shandong University; Beijing Tongren Hospital; Beijing Hospital and other collaborators

Not yet recruiting

Zanubrutinib and Eltrombopag as Second-line Treatment in Adults With Primary Immune Thrombocytopenia

Immune Thrombocytopenia

China
Peking University People's Hospital

Recruiting

The Combination of Prednisone and Recombinant Human Thrombopoietin for Treatment of Immune Thrombocytopenia in Pregnancy

Immune Thrombocytopenia

China
Peking University People's Hospital

Not yet recruiting

Efficacy and Safety of Iguratimod in the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Immune Thrombocytopenia

China
Peking University People's Hospital

Not yet recruiting

A Study of Orelabrutinib in Patients With ITP

Immune Thrombocytopenia

China
Peking University People's Hospital

Not yet recruiting

The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Immune Thrombocytopenia

China
Peking University People's Hospital
Qilu Hospital of Shandong University; Beijing Tongren Hospital; Beijing Hospital and other collaborators

Completed

The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

Immune Thrombocytopenia

China
Peking University People's Hospital

Unknown

Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER)

Immune Thrombocytopenia

China
Shandong University
Qingdao University; Liaocheng People's Hospital; Linyi People's Hospital

Unknown

DEX Combined With RTX, CSA and IVIG in the Management of Newly Diagnosed ITP Patients

Immune Thrombocytopenia

China
Yin Jie

Recruiting

Herombopag + rhTPO in Severe Immune Thrombocytopenia

Immune Thrombocytopenia

China
Ming Hou

Completed

The Serum Lipid Profiles in ITP: a Retrospective Study

Immune Thrombocytopenia

China
Shandong University
The Affiliated Hospital of Qingdao University; Yantai Yuhuangding Hospital

Unknown

Rituximab Combining Bortezomib Versus Rituximab in Management of ITP

Purpura, Thrombocytopenic, Idiopathic | Immune Thrombocytopenia

China
Shandong University

Completed

The Study of Different Dose Rituximab in the Treatment of ITP

Purpura, Thrombocytopenic, Idiopathic | Immune Thrombocytopenia

China
Shandong University

Unknown

A Single-center Clinical Trial of Bortezomib in Management of Immune Thrombocytopenia (ITP) (ITP)

Immune Thrombocytopenia

China
Shandong University
Shandong Provincial Hospital; The First Affiliated Hospital of Dalian Medical...

Completed

An Investigation of rhTPO With Different Frequencies in the Management of ITP

Immune Thrombocytopenia

China
Shandong University
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences; Shenzhen Second People's Hospital and other collaborators

Withdrawn

High-dose Dexamethasone Combining Thalidomide Versus Dexamethasone Mono-therapy for Management of Newly-diagnosed ITP

Immune Thrombocytopenia

China
Shandong University

Withdrawn

A Multicenter Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Cyclosporin A Versus Cyclosporin A in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）

Immune Thrombocytopenia

China
Shandong University
Qingdao University; Shandong Provincial Hospital; Qianfoshan Hospital; Anhui Medical...

Completed

Caffeic Acid Tablets as a Second-line Therapy for ITP

Immune Thrombocytopenia

China
Institute of Hematology & Blood Diseases Hospital...
Henan Cancer Hospital; Tianjin Medical University Second Hospital; The Second... and other collaborators

Recruiting

A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia

Immune Thrombocytopenia | Treatment

China
Institute of Hematology & Blood Diseases Hospital

Recruiting

A Prospective, One-arm and Open Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia (2022-CM313-ITP)

Immune Thrombocytopenia | Treatment

China
Peking University People's Hospital
Beijing Friendship Hospital; Beijing Hospital; The First Affiliated Hospital... and other collaborators

Recruiting

The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

Immune Thrombocytopenia | ITP

China
Zhang Lei

Recruiting

Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients

Thrombocytopenia | Splenectomy

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients

Purpura, Thrombocytopenic, Idiopathic

China
Shandong University

Recruiting

Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP

Immune Thrombocytopenia

China
Shandong University
Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Shandong... and other collaborators

Unknown

Decitabine Combining Dexamethasone Versus Dexamethasone in Management of ITP

Purpura, Thrombocytopenic, Idiopathic | Immune Thrombocytopenia

China
Shandong University
Peking University People's Hospital; The Affiliated Hospital of Qingdao University and other collaborators

Unknown

Recombinant Human Thrombopoietin(rhTPO) in Pregnancy With Immune Thrombocytopenia

Immune Thrombocytopenia

China
Shandong University
Qianfoshan Hospital; Jinan Central Hospital

Unknown

RP% Measurement by FCM as a Diagnostic Test for ITP

Immune Thrombocytopenia

China
Ming Hou
Peking Union Medical College Hospital; Cancer Institute and Hospital, Chinese... and other collaborators

Withdrawn

Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia (Incritop)

Purpura, Thrombocytopenic, Idiopathic

China
Shandong University
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Withdrawn

Alteration of Different Immune Parameters in Immune Thrombocytopenia （ITP） Patients Receiving Eltrombopag Treatment

Immune Thrombocytopenia

China
Shandong University

Withdrawn

A Multicentre Investigation of 2 Cycles Rituximab Compared With Standard Regimen in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）

Immune Thrombocytopenia

China
Shandong University
Peking Union Medical College Hospital; Cancer Institute and Hospital, Chinese... and other collaborators

Completed

An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP)

Immune Thrombocytopenia

China
Shandong University

Not yet recruiting

Atorvastatin in Management of Newly Diagnosed ITP

Purpura, Thrombocytopenic | Immune Thrombocytopenia

China

Clinical Trials on Platelet Coagulation Disorders in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations